Biguanides are used to treat T2DM by causing reductions in the absorption of glucose from the intestine and hepatic glucose output via a decrease in gluconeogenesis and stimulating glycolysis stimulation; meanwhile, biguanides lead to an increase in insulin signaling by increasing insulin receptor activity [13]. This evidence concerns the gene INS and type 2 diabetes mellitus.